7600.T
Toshiba provides a range of healthcare services and equipment, including medical imaging systems, diagnostic equipment, and related solutions.
Business. 7600.T is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
7600.T is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.
Toshiba's capital structure shows a debt-to-equity ratio of 0.13, indicating a relatively low level of leverage compared to industry norms. The company's liquidity position is characterized by a current ratio of 3.29, suggesting strong short-term liquidity. However, the company's free cash flow is negative at -835,278,000 JPY, which may indicate challenges in generating sufficient cash from operations to fund its capital expenditures.
Profitability metrics reveal a concerning trend, with a return on equity of -1.87% and a return on assets of -1.37%. These figures are below the industry median and suggest that the company is not effectively utilizing its equity and assets to generate profits. The operating margin is also negative, with an operating income of -275,094,000 JPY, further highlighting the company's operational inefficiencies.
Toshiba's revenue is primarily concentrated in the healthcare services and equipment segment, with no significant geographic diversification disclosed. The company's exposure to a single business line increases its vulnerability to market fluctuations in the healthcare sector. There is no indication of substantial international operations, which may limit its growth potential in emerging markets.
The company's growth trajectory is mixed, with a slight decline in revenue from the previous year. Analysts estimate a mean revenue of 24,500,000,000 JPY for the current fiscal year, which is slightly below the actual revenue of 25,114,000,000 JPY. This suggests a potential slowdown in revenue growth, which could impact the company's ability to meet its financial obligations and invest in future growth opportunities.
Risk factors for Toshiba include a negative net cash position after subtracting total debt, which could affect its financial flexibility. The company's liquidity risk is rated as medium, and while dilution risk is currently low, the negative free cash flow and operating income may necessitate additional financing in the future. The company's recent financial performance, including a net loss of 461,798,000 JPY, further underscores the need for careful financial management.
Recent events, including the company's financial performance and analyst estimates, indicate a challenging operating environment. The company's negative operating and net income, coupled with a negative free cash flow, suggest that it may need to implement cost-cutting measures or seek additional financing to stabilize its financial position. The company's management will need to address these issues to restore investor confidence and improve its financial performance.
- Toshiba's capital structure is relatively low in leverage, but its negative free cash flow indicates operational challenges.
- The company's profitability metrics are below industry medians, with a negative return on equity and assets.
- Revenue is concentrated in a single business segment, increasing vulnerability to market fluctuations.
- Analyst estimates suggest a potential slowdown in revenue growth, which could impact financial stability.
- The company faces liquidity and dilution risks, necessitating careful financial management.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 16,30 |
| Revenue | —no estimate | —no estimate | 24,5B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- 7600.T Market data — financials · 2026-05-27
- Japan Medical Dynamic Marketing Inc Market data — analyst estimates · 2026-05-27